The Russian government plans to expand the list of vital and essential drugs with new drugs
Quick Look
The Russian government is considering a draft order to include new drugs in the list of vital and essential drugs, including Arogleptol for type 2 diabetes and Verenafusp alfa for a hereditary metabolic disease, which will lead to state regulation of prices and control of trade markups.
AI-generated summary
Why It Matters
The list of VEDs (vital and essential drugs) is subject to periodic updating and regulation by the state to ensure the availability of important medications.
The list of vital and essential drugs (VED) may be supplemented with new drugs. RIA Novosti reports this with reference to a draft order of the Russian government.
It is clarified that the expansion of the list of vital and essential drugs means that state regulation of maximum selling prices of manufacturers will begin to apply for the listed drugs. In addition, control of trade markups will come into force.
Thus, they wanted to include “Arogleptol” (prescribed for type 2 diabetes mellitus), “Verenafusp alfa” (for hereditary metabolic diseases) and other drugs in the list.
What to Watch
AI outlook — possibilities, not facts
The draft order to expand the list of vital and essential drugs will be approved in the coming weeks
Likely · Within weeks
Open Questions
- When exactly will the expansion of the VED list be approved?
- What other medications besides those mentioned may be included?
- What will be the level of discounts or surcharges once the regulation comes into force?
